ASX News Health Care Immutep notches upward on first lung cancer patient dosing Immutep Ltd has dosed the first patient of its Phase 3 TACTI-004 non-small cell lung cancer… 2 mins25 March 2025 11:17 (AEST)
ASX News Health Care Immutep dips as safety test for flagship drug IMP761 shows no adverse effects Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has… 1 min17 December 2024 10:27 (AEST)